|
|
|
|
A comparison of currently available direct acting antiviral HCV therapy in Canada - On the path to elimination
|
|
|
Reported by Jules Levin
International Liver Congress (EASL), 10-14 April 2019, Vienna, Austria
A. ALIMOHAMMADI1, J. HOLEKSA1, T. MAGEL1, D. TRUONG1, A. THIAM1, R. YUNG1, L. CHU1, B. CONWAY1
1 Vancouver Infectious Diseases Centre, Vancouver, Canada
|
|
|
|
|
|
|